Doron Gerber

Chirality-independent protein-protein recognition between transmembrane domains in vivo.

The composition rather than position of polar residues (QxxS) drives aspartate receptor transmembrane domain dimerization in vivo.

Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization.

Structural adaptation of the glycophorin A transmembrane homodimer to D-amino acid modifications.

Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex.

Hetero-assembly between all-L- and all-D-amino acid transmembrane domains: forces involved and implication for inactivation of membrane proteins.

From genome to antivirals: SARS as a test tube.

D-enantiomer peptide of the TCRalpha transmembrane domain inhibits T-cell activation in vitro and in vivo.

The identification of a minimal dimerization motif QXXS that enables homo- and hetero-association of transmembrane helices in vivo.

HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif.

A structurally altered D,L-amino acid TCRalpha transmembrane peptide interacts with the TCRalpha and inhibits T-cell activation in vitro and in an animal model.

Specificity in transmembrane helix-helix interactions mediated by aromatic residues.

Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis.

An in vitro microfluidic approach to generating protein-interaction networks.

De novo identification and biophysical characterization of transcription-factor binding sites with microfluidic affinity analysis.

Transmembrane domains interactions within the membrane milieu: Principles, advances and challenges.

Sperm epidermal growth factor receptor (EGFR) mediates α7 acetylcholine receptor (AChR) activation to promote fertilization.